Streetbeat News

Price Targets

TFX

CL King has initiated coverage on Teleflex (NYSE:TFX) with a Buy rating and a price target of $293.

Portfolio Pulse from Benzinga Newsdesk

May 30, 2023 | 3:53 pm

RAIN

Roth MKM analyst Raja Kumaraguru downgraded Rain Oncology (NASDAQ:RAIN) from Buy to Neutral and announced a $1.2 price target.

Portfolio Pulse from Benzinga Newsdesk

May 30, 2023 | 3:47 pm

CSCO

A whale has taken a bullish stance on Cisco Systems (NASDAQ:CSCO) with 57% of investors opening trades with bullish expectations and 42% with bearish. Whales have been targeting a price range of $45.0 to $52.5 for Cisco Systems over the last 3 months. Credit Suisse, Piper Sandler, Barclays, and Deutsche Bank maintain their ratings, while Oppenheimer downgraded to Outperform with a price target of $58.

Portfolio Pulse from Benzinga Insights

May 30, 2023 | 3:46 pm

IOVA

Wells Fargo analyst Yanan Zhu upgraded Iovance Biotherapeutics (NASDAQ:IOVA) from Equal-Weight to Overweight and raised the price target from $11 to $17.

Portfolio Pulse from Benzinga Newsdesk

May 30, 2023 | 3:39 pm

LLY

A whale has taken a bearish stance on Eli Lilly (NYSE:LLY) with 72% of detected unusual options trades being bearish. The price target range for Eli Lilly over the last 3 months is $160 to $520. Analysts maintain Outperform and Overweight ratings with price targets between $458 and $507.

Portfolio Pulse from Benzinga Insights

May 30, 2023 | 3:18 pm

TSLA

A whale has taken a bearish stance on Tesla (NASDAQ:TSLA) with 160 unusual options trades detected. 49% of investors opened trades with bullish expectations and 50% with bearish. Whales have been targeting a price range of $170 to $250 for Tesla over the last 3 months. Wedbush downgraded its action to Outperform with a price target of $215, while Piper Sandler maintained their Overweight rating with a price target of $280.

Portfolio Pulse from Benzinga Insights

May 30, 2023 | 3:17 pm

RMTI

HC Wainwright & Co maintained a Buy rating on RMTI stock and raised its price target from $7 to $9, causing the shares to trade higher.

Portfolio Pulse from Benzinga Newsdesk

May 30, 2023 | 3:16 pm

PTN

HC Wainwright & Co. analyst Joseph Pantginis reiterates a Buy rating on Palatin Techs (AMEX:PTN) and maintains a $70 price target.

Portfolio Pulse from Benzinga Newsdesk

May 30, 2023 | 3:13 pm

DXCM

In the last 3 months, 9 analysts have provided 12-month price targets for DexCom (NASDAQ:DXCM), with an average price target of $134.11, up 5.71% from the previous average of $126.86. The company has received 7 bullish ratings, 2 indifferent ratings, and no bearish ratings.

Portfolio Pulse from Benzinga Insights

May 30, 2023 | 3:10 pm

RAIN

EF Hutton analyst Tony Butler maintains a Hold rating on Rain Oncology (NASDAQ:RAIN) and lowers the price target from $5 to $2.

Portfolio Pulse from Benzinga Newsdesk

May 30, 2023 | 2:50 pm